(Q36543076)

14 August 2017

1 reference

title

Novel gene-directed enzyme prodrug therapies against prostate cancer (English)

1 reference

14 August 2017

1 reference

Pamela J Russell

1

0 references

author name string

Aparajita Khatri

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Investigational Drugs

14 August 2017

published in

1 reference

14 August 2017

volume

15

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

947-961

1 reference

Gene-based therapy in prostate cancer

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Targeting gene therapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Gene therapy of prostate cancer: current and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Immune system in suicide-gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Relative activity and specificity of promoters from prostate-expressed genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Identification and characterization of a prostate-specific androgen-independent protein-binding site in the probasin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

p53 oncogene mutations in three human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Transcription-targeted gene therapy for androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Aerobic 2- and 4-nitroreduction of CB 1954 by human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.8.947

10.1517/13543784.15.8.947

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference